| Respiratory tract (n = 136) | No respiratory tract (n = 25) | p value |
Gender |
|
|
|
Male | 90 | 12 | 0.08 |
Female | 46 | 13 |
|
Age |
|
|
|
0 - 1 | 6 | 2 | 0.80 |
1 - 18 | 122 | 9 | <0.01 |
19 - 64 | 5 | 12 | <0.01 |
65- | 3 | 2 | 0.36 |
Season |
|
|
|
Spring | 42 | 7 | 0.77 |
Summer | 31 | 8 | 0.32 |
Fall | 28 | 4 | 0.80 |
Winter | 35 | 6 | 0.85 |
Antomicrobial susceptibility |
|
|
|
Minocycline susceptible | 111 | 21 | 1.00 |
Minocycline no susceptible | 25 | 4 |
|
Clarithromycin susceptible | 45 | 17 | <0.01 |
Clarithromycin no susceptible | 91 | 8 |
|
Clindamycin susceptible | 98 | 21 | 0.32 |
Clindamycin no susceptible | 38 | 4 |
|
Ciprofloxacin susceptible | 90 | 16 | 0.83 |
Ciprofloxacin no susceptible | 46 | 9 |
|